How to reduce the incidence of contrast induced acute kidney injury after cardiac (invasive) procedures, a review and practical recommendations

References

• Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994;331:1449-50
   PubMed Web of Science ®Google Scholar
• Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8
   PubMed Web of Science ®Google Scholar
• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94
   PubMed Web of Science ®Google Scholar
• McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. Rev Cardiovasc Med 2006;7:177-97
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64
   PubMed Web of Science ®Google Scholar
• Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-75
   PubMed Web of Science ®Google Scholar
• Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-5
   PubMed Web of Science ®Google Scholar
• Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19
   PubMed Web of Science ®Google Scholar
• Solomon R. Contrast-induced acute kidney injury and long-term oucomes: are they connected. J Invasive Cardiol 2009;21:23B-5B (Abstract)
   Google Scholar
• Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997;203:605-10
   Google Scholar
• Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615-20
   PubMed Web of Science ®Google Scholar
• Hall KA, Wong RW, Hunter GC, et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992;53:317-20
   PubMed Web of Science ®Google Scholar
• Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22
   PubMed Web of Science ®Google Scholar
• Oldroyd SD, Fang L, Haylor JL, et al. Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney. Clin Sci (Lond) 2000;98:303-11
   PubMed Web of Science ®Google Scholar
• Deray G, Martinez F, Cacoub P, et al. A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990;10:316-22
   PubMed Web of Science ®Google Scholar
• Fujisaki K, Kubo M, Masuda K, et al. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Clin Exp Nephrol 2003;7:279-83
   PubMedGoogle Scholar
• Sendeski M, Patzak A, Pallone TL, et al. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009;251:697-704
   PubMed Web of Science ®Google Scholar
• Sendeski M, Patzak A, Persson PB. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents. Invest Radiol 2010;45:453-7
   PubMed Web of Science ®Google Scholar
• Dawson P. Cardiovascular effects of contrast agents. Am J Cardiol 1989;64:2E-9E
   PubMed Web of Science ®Google Scholar
• Neagley SR, Vought MB, Weidner WA, et al. Transient oxygen desaturation following radiographic contrast medium administration. Arch Intern Med 1986;146:1094-7
   PubMed Web of Science ®Google Scholar
• Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999;34:685-91
   PubMed Web of Science ®Google Scholar
• Kim SJ, Salem MR, Joseph NJ, et al. Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg 1990;71:73-6
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Khamaisi M, et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010;45:188-95
   PubMed Web of Science ®Google Scholar
• Duan S, Zhou X, Liu F, et al. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. J Nephrol 2006;19:717-24
   PubMed Web of Science ®Google Scholar
• Hardiek K, Katholi RE, Ramkumar V, et al. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 2001;280:F61-F70
   PubMed Web of Science ®Google Scholar
• Weisbord SD, Mor MK, Resnick AL, et al. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 2008;168:1325-32
   PubMed Web of Science ®Google Scholar
• Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;S11-S15
   PubMedGoogle Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9
   PubMed Web of Science ®Google Scholar
• Kurnik BR, Allgren RL, Genter FC, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-80
   PubMed Web of Science ®Google Scholar
• Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-61
   PubMed Web of Science ®Google Scholar
• McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98:27K-36K
   PubMed Web of Science ®Google Scholar
• Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8
   PubMed Web of Science ®Google Scholar
• Dawson P, Howell M. The non-ionic dimers: a new class of contrast agents. Br J Radiol 1986;59:987-91
   PubMed Web of Science ®Google Scholar
• McCullough PA, Bertrand ME, Brinker JA, et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006;48:692-9
   PubMed Web of Science ®Google Scholar
• Reed M, Meier P, Tamhane UU, et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 2009;2:645-54
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Haberle L, Muller V, et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009;250:68-86
   PubMed Web of Science ®Google Scholar
• Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009;150:170-7
   PubMed Web of Science ®Google Scholar
• Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-52
   PubMed Web of Science ®Google Scholar
• Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol 1981;136:859-61
   PubMed Web of Science ®Google Scholar
• Dussol B, Morange S, Loundoun A, et al. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 2006;21:2120-6
   PubMed Web of Science ®Google Scholar
• Krasuski RA, Beard BM, Geoghagan JD, et al. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol 2003;15:699-702
   PubMedGoogle Scholar
• Taylor AJ, Hotchkiss D, Morse RW, et al. PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998;114:1570-4
   PubMed Web of Science ®Google Scholar
• Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003;93:C29-C34
   PubMed Web of Science ®Google Scholar
• Bader BD, Berger ED, Heede MB, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 2004;62:1-7
   PubMed Web of Science ®Google Scholar
• Clavijo LC, Pinto TL, Kuchulakanti PK, et al. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. Am J Cardiol 2006;97:981-3
   PubMed Web of Science ®Google Scholar
• Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006;98:59K-77K
   PubMed Web of Science ®Google Scholar
• Alpern RJ. The Kidney, 6th Philadelphia, PA: WB Saunders, 2000:455-519
   Google Scholar
• Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85
   PubMed Web of Science ®Google Scholar
• Cohen G. CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press Inc., 1985:55-64
   Google Scholar
• Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34
   PubMed Web of Science ®Google Scholar
• Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 2007;49:1283-8
   PubMed Web of Science ®Google Scholar
• Atkins JL. Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron 1986;44:70-4
   PubMed Web of Science ®Google Scholar
• Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008;300:1038-46
   PubMed Web of Science ®Google Scholar
• Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008;52:599-604
   PubMed Web of Science ®Google Scholar
• Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009;151:631-8
   PubMed Web of Science ®Google Scholar
• Hoste EA, De Waele JJ, Gevaert SA, et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 2010;25:747-58
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ, Joannidis M. Increasing evidence base for sodium bicarbonate therapy to prevent contrast media-induced acute kidney injury: little role of unpublished studies. Nephrol Dial Transplant 2010;25:650-4
   PubMed Web of Science ®Google Scholar
• McCullough PA. Radiocontrast-induced acute kidney injury. Nephron Physiol 2008;109:61-72
   Google Scholar
• Goergen SK, Rumbold G, Compton G, et al. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 2010;254:261-9
   PubMed Web of Science ®Google Scholar
• Tepel M, van der GM, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4
   PubMed Web of Science ®Google Scholar
• Coyle LC, Rodriguez A, Jeschke RE, et al. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J 2006;151:1032-12
   PubMed Web of Science ®Google Scholar
• Gomes VO, Poli de Figueredo CE, Caramori P, et al. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 2005;91:774-8
   PubMed Web of Science ®Google Scholar
• Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8
   PubMed Web of Science ®Google Scholar
• Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82
   PubMed Web of Science ®Google Scholar
• Ochoa A, Pellizzon G, Addala S, et al. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. J Interv Cardiol 2004;17:159-65
   PubMedGoogle Scholar
• Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008;148:284-94
   PubMed Web of Science ®Google Scholar
• Trivedi H, Daram S, Szabo A, et al. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 2009;122:874-15
   PubMedGoogle Scholar
• Berwanger O, Sousa A, Cavalcanti A, et al. Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a pragmatic multicenter randomized trial to evaluate the efficacy of acetylcysteine for the prevention of renal outcomes in patients undergoing coronary and vascular angiography. Abstract presented at AHA scientific sessions 2010 (abstract)
   Google Scholar
• Arend LJ, Bakris GL, Burnett JC Jr, et al. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987;110:406-11
   PubMed Web of Science ®Google Scholar
• Arakawa K, Suzuki H, Naitoh M, et al. Role of adenosine in the renal responses to contrast medium. Kidney Int 1996;49:1199-206
   PubMed Web of Science ®Google Scholar
• Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999;83:260-3, A5
   PubMed Web of Science ®Google Scholar
• Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994;45:1425-31
   PubMed Web of Science ®Google Scholar
• Erley CM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999;14:1146-9
   PubMed Web of Science ®Google Scholar
• Gandhi MR, Brown P, Romanowski CA, et al. The use of theophylline, an adenosine antagonist in the prevention of contrast media induced nephrotoxicity. Br J Radiol 1992;65:838
   PubMed Web of Science ®Google Scholar
• Huber W, Ilgmann K, Page M, et al. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 2002;223:772-9
   PubMed Web of Science ®Google Scholar
• Huber W, Schipek C, Ilgmann K, et al. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol 2003;91:1157-62
   PubMed Web of Science ®Google Scholar
• Kapoor A, Kumar S, Gulati S, et al. The role of theophylline in contrast-induced nephropathy: a case–control study. Nephrol Dial Transplant 2002;17:1936-41
   PubMed Web of Science ®Google Scholar
• Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995;195:17-22
   PubMed Web of Science ®Google Scholar
• Kolonko A, Wiecek A, Kokot F. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents. J Nephrol 1998;11:151-6
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Ghali WA. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med 2005;165:1087-93
   PubMed Web of Science ®Google Scholar
• Lee HT, Jan M, Bae SC, et al. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 2006;290:F1367-75
   PubMed Web of Science ®Google Scholar
• Kierdorf H, Kindler J, Winterscheid R, et al. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd 1989;128:119-23
   PubMedGoogle Scholar
• Furukawa T, Ueda J, Takahashi S, et al. Elimination of low-osmolality contrast media by hemodialysis. Acta Radiol 1996;37:966-71
   PubMed Web of Science ®Google Scholar
• Sterner G, Frennby B, Mansson S, et al. Assessing residual renal function and efficiency of hemodialysis – an application for urographic contrast media. Nephron 2000;85:324-33
   PubMedGoogle Scholar
• Matzkies FK, Tombach B, Kisters K, et al. Clearance of iopromide during haemodialysis with high- and low-flux membranes. Acta Radiol 1999;40:220-3
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Dialysis and contrast media. Eur Radiol 2002;12:3026-30
   PubMed Web of Science ®Google Scholar
• Cruz DN, Perazella MA, Bellomo R, et al. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis 2006;48:361-71
   PubMed Web of Science ®Google Scholar
• Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 2007;50:1015-20
   PubMed Web of Science ®Google Scholar
• Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1333-40
   PubMed Web of Science ®Google Scholar
• Marenzi G, Lauri G, Campodonico J, et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006;119:155-62
   PubMed Web of Science ®Google Scholar
• Goel R, Berns JS. Can continuous venovenous hemofiltration prevent contrast-induced nephropathy: is the dye already cast? Semin Dial 2007;20:93-5
   PubMedGoogle Scholar
• Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-55
   PubMed Web of Science ®Google Scholar
• Lloberas N, Torras J, Herrero-Fresneda I, et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. FASEB J 2002;16:908-10
   PubMed Web of Science ®Google Scholar
• Durak I, Ozbek H, Karaayvaz M, et al. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol 2002;25:1-8
   PubMed Web of Science ®Google Scholar
• Ali BH. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food Chem Toxicol 2003;41:1447-52
   PubMed Web of Science ®Google Scholar
• Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-42
   PubMed Web of Science ®Google Scholar
• Boscheri A, Weinbrenner C, Botzek B, et al. Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 2007;68:279-86
   PubMed Web of Science ®Google Scholar
• Brezis M, Rosen S. Hypoxia of the renal medulla – its implications for disease. N Engl J Med 1995;332:647-55
   PubMed Web of Science ®Google Scholar
• Schlondorff D. Renal prostaglandin synthesis. Sites of production and specific actions of prostaglandins. Am J Med 1986;81:1-11
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994;2:153-7
   PubMedGoogle Scholar
• Krause W, Muschick P, Kruger U. Use of near-infrared reflection spectroscopy to study the effects of X-ray contrast media on renal tolerance in rats: effects of a prostacyclin analogue and of phosphodiesterase inhibitors. Invest Radiol 2002;37:698-705
   PubMed Web of Science ®Google Scholar
• Sendo T, Sumimura T, Itoh Y, et al. Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cell Signal 2003;15:773-81
   PubMed Web of Science ®Google Scholar
• Spargias K, Adreanides E, Demerouti E, et al. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2009;120:1793-9
   PubMed Web of Science ®Google Scholar
• Lanese DM, Yuan BH, Falk SA, et al. Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 1991;261:F1102-9
   PubMed Web of Science ®Google Scholar
• Morikawa S, Sone T, Tsuboi H, et al. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 2009;53:1040-6
   PubMed Web of Science ®Google Scholar
• Roy DR. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 1986;251:F220-5
   PubMed Web of Science ®Google Scholar
• Davis CL, Briggs JP. Effect of atrial natriuretic peptides on renal medullary solute gradients. Am J Physiol 1987;253:F679-84
   PubMed Web of Science ®Google Scholar
• Meyer-Lehnert H, Bayer T, Predel HG, et al. Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure. Klin Wochenschr 1991;69:895-903
   PubMedGoogle Scholar
• Sandok EK, Lerman A, Stingo AJ, et al. Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor. J Am Soc Nephrol 1992;3:196-202
   PubMed Web of Science ®Google Scholar
• Nakamoto M, Shapiro JI, Shanley PF, et al. In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 1987;80:698-705
   PubMed Web of Science ®Google Scholar
• Valsson F, Ricksten SE, Hedner T, et al. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. J Cardiothorac Vasc Anesth 1994;8:425-30
   PubMedGoogle Scholar
• Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994;45:1731-8
   PubMed Web of Science ®Google Scholar
• Yukimura T, Ito K, Takenaga T, et al. Renal effects of a synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized dogs. Eur J Pharmacol 1984;103:363-6
   PubMed Web of Science ®Google Scholar
• Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-65
   PubMed Web of Science ®Google Scholar
• Attallah N, Yassine L, Musial J, et al. The potential role of statins in contrast nephropathy. Clin Nephrol 2004;62:273-8
   PubMed Web of Science ®Google Scholar
• Jo SH, Koo BK, Park JS, et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial – a randomized controlled study. Am Heart J 2008;155:499-8
   PubMed Web of Science ®Google Scholar
• Toso A, Maioli M, Leoncini M, et al. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease. Am J Cardiol 2010;105:288-92
   PubMed Web of Science ®Google Scholar
• Shaker OG, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 2010;61:731-6
   PubMed Web of Science ®Google Scholar